Glow-in-the-Dark dye could help surgeons remove brain tumors more precisely
NCT ID NCT07493447
First seen Mar 29, 2026 · Last updated May 22, 2026 · Updated 10 times
Summary
This early-stage study tests a fluorescent dye called panitumumab-IRDye800 that attaches to cancer cells and glows under special lights. About 30 adults with brain tumors (like meningioma or glioblastoma) will receive the dye before surgery to help surgeons see tumor tissue more clearly. The goal is to improve how completely tumors are removed while protecting healthy brain tissue.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.